Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 45 of the 45 references it cites were found in a registry or an index.

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis

Abstract

BACKGROUND: Guidelines advocate changes in fatty acid consumption to promote cardiovascular health. PURPOSE: To summarize evidence about associations between fatty acids and coronary disease. DATA SOURCES: MEDLINE, Science Citation Index, and Cochrane Central Register of Controlled Trials through July 2013. STUDY SELECTION: Prospective, observational studies and randomized, controlled trials. DATA EXTRACTION: Investigators extracted data about study characteristics and assessed study biases. DATA SYNTHESIS: There were 32 observational studies (530,525 participants) of fatty acids from dietary intake; 17 observational studies (25,721 participants) of fatty acid biomarkers; and 27 randomized, controlled trials (103,052 participants) of fatty acid supplementation. In observational studies, relative risks for coronary disease were 1.02 (95% CI, 0.97 to 1.07) for saturated, 0.99 (CI, 0.89 to 1.09) for monounsaturated, 0.93 (CI, 0.84 to 1.02) for long-chain ω-3 polyunsaturated, 1.01 (CI, 0.96 to 1.07) for ω-6 polyunsaturated, and 1.16 (CI, 1.06 to 1.27) for trans fatty acids when the top and bottom thirds of baseline dietary fatty acid intake were compared. Corresponding estimates for circulating fatty acids were 1.06 (CI, 0.86 to 1.30), 1.06 (CI, 0.97 to 1.17), 0.84 (CI, 0.63 to 1.11), 0.94 (CI, 0.84 to 1.06), and 1.05 (CI, 0.76 to 1.44), respectively. There was heterogeneity of the associations among individual circulating fatty acids and coronary disease. In randomized, controlled trials, relative risks for coronary disease were 0.97 (CI, 0.69 to 1.36) for α-linolenic, 0.94 (CI, 0.86 to 1.03) for long-chain ω-3 polyunsaturated, and 0.89 (CI, 0.71 to 1.12) for ω-6 polyunsaturated fatty acid supplementations. LIMITATION: Potential biases from preferential publication and selective reporting. CONCLUSION: Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats. PRIMARY FUNDING SOURCE: British Heart Foundation, Medical Research Council, Cambridge National Institute for Health Research Biomedical Research Centre, and Gates Cambridge.

Overview

Integrity signals

Registry

Crossref · 10.7326/m13-1788

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Riboli E, 1987, Cancer Surv, 6, 685

Cited by

See all 1,139

Metadata

Authors
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., Khaw, K.-T., Mozaffarian, D., Danesh, J., & Di Angelantonio, E.
Affiliations
  • Harvard University (US)
  • From the University of Cambridge and Medical Research Council, Cambridge, United Kingdom; Harvard School of Public Health, Boston, Massachusetts; University of Oxford, Oxford, United Kingdom; School of Public Health, Imperial College London, London, United Kingdom; Centre for Exercise, Nutrition and Health Sciences, University of Bristol, Bristol, United Kingdom; and Erasmus University Medical Center, Rotterdam, the Netherlands.
Venue
Annals of Internal Medicine
Published
2014-03-18
Volume
160
Issue
6
Pages
398-406
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2102323857
Cited by
1,139
References
44
Citations by year
2026: 14 · 2025: 29 · 2024: 43 · 2023: 54 · 2022: 71 · 2021: 81 · 2020: 87 · 2019: 93 · 2018: 139 · 2017: 127 · 2016: 159 · 2015: 150 · 2014: 84
FWCI
19.84
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0512-10114)
  • British Heart Foundation (RG/13/13/30194, RG/08/014/24067)
  • Medical Research Council (MC_UU_12015/5, MR/L003120/1)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Nursing › Nutrition and Dietetics › Nuts composition and effects
Keywords
dietary fatty acids, coronary artery disease, saturated fatty acids, monounsaturated fatty acids, omega-3 polyunsaturated fatty acids, omega-6 fatty acids, trans fatty acids, circulating fatty acids, fatty acid supplementation, alpha-linolenic acid, n-3 long-chain polyunsaturated fatty acids, cardiovascular risk, dietary guidelines, n-6/n-3 ratio
MeSH terms
Coronary Disease, Dietary Fats, Fatty Acids, Fatty Acids, Unsaturated, Humans, Risk Factors, Biomarkers, Diet, Fat-Restricted, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.7326/m13-1788
The paper
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., Khaw, K.-T., Mozaffarian, D., Danesh, J., & Di Angelantonio, E. (2014). Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis. Annals of Internal Medicine. https://doi.org/10.7326/m13-1788

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.